Skip to main content

What Corteva's latest 10-Q says: 4 signals

Corteva filed its latest 10-Q with the SEC on Jul 31, 2026. It discusses acquisition completed, environmental liability and manufacturing issue.

Public (CTVA)Farming10,000+ employeescorteva.comLinkedIn

10-Q · latest 9

What Corteva's 10-Q filings say

  1. 10-Q

    Filed · 4 signals

    SEC EDGAR
  2. 10-Q

    Filed · 5 signals

    SEC EDGAR

Earnings calls

Corteva earnings headlines

From earnings call transcripts (Signal API type earnings-transcripts).

Earnings call headlines
Call dateWhat the company said
Intends to separate into two public companies by H2 2026The company is undergoing a massive strategic separation of its Seed and Crop Protection businesses. This will create two new independent companies, triggering a complete review of all systems, processes, and vendor contracts, opening significant opportunities for new suppliers.
Planning massive strategic separation into two public companies by H2 2026.The company is undergoing a complete separation of its Seed and Crop Protection businesses, creating immense opportunities for consulting, legal, financial, and IT services to manage the complex transition.
Facing competitive pricing pressure in Crop Protection, especially in BrazilExecutives acknowledge ongoing competitive pricing dynamics, which are impacting margins in the Crop Protection business, particularly in Latin America. This pressure makes them receptive to solutions that can improve efficiency, differentiate their offerings, or provide better market intelligence.
Driving over $600M in controllable cost benefits and productivity gainsThe company has a strong, ongoing focus on operational efficiency and cost reduction, exceeding its initial targets. This creates opportunities for vendors offering solutions that automate processes, reduce operational costs, optimize supply chains, or improve margins.
Betting on AI and gene editing as transformative growth drivers.Leadership explicitly cited AI and gene editing as key technologies changing the industry landscape and driving their strategic separation. This focus signals investment in AI/ML platforms, computational biology tools, and data science talent to maintain a competitive edge.
Investing in a $9B R&D pipeline and launching new products like VarpelgoThe company is heavily focused on innovation, with a $9B technology pipeline and the upcoming launch of a new insecticide, Varpelgo. This focus on new product introduction creates needs for R&D support, clinical trial management, marketing automation, and sales enablement tools.

Signal API · MCP

Track Corteva with the Signal API

One POST /v1/companies/enrich call with corteva.com returns Corteva 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"corteva.com","signal_types":["sec-10q"],"limit":20}'

Same industry

Questions about Corteva 10-Q

When did Corteva file its latest 10-Q?
Corteva filed its latest 10-Q on Jul 31, 2026. The one before it was filed on May 6, 2026.
What did Corteva disclose in its latest 10-Q?
From the filing dated Jul 31, 2026: Corteva faces EPA demand for PFAS cleanup costs and liability from reservoir collapse.
What did Corteva say on its recent earnings calls?
Q3 FY2025: Intends to separate into two public companies by H2 2026 (dated Nov 5, 2025).
Where can I read Corteva's 10-Q filing?
The full filing is on SEC EDGAR: https://www.sec.gov/Archives/edgar/data/30554/000175567226000025/ctva-20260630.htm. This page summarizes what the filing says and links to it.

Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.

Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.

Data as of .

How this data is built →Get it from the Signal API →